Clinical trial
Etirinotecan Pegol (NKTR-102) in NSCLC
NCT01773109
Study timeline
Study start (unknown)2013-01-01Date precision: month
Registry last updated2020-04-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Non Small Cell Lung Cancerunresolved
Recurrent Non Small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
Abramson Cancer Center at Penn Medicinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01773109 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.